STIFEL FINANCIAL CORP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,217
-10.8%
33,213
+0.5%
0.00%
Q2 2023$38,351
-26.7%
33,063
-4.6%
0.00%
Q1 2023$52,338
-41.7%
34,659
-3.4%
0.00%
Q4 2022$89,715
-54.9%
35,881
-23.9%
0.00%
Q3 2022$199,000
+49.6%
47,179
-0.9%
0.00%
Q2 2022$133,000
-52.8%
47,607
-3.5%
0.00%
Q1 2022$282,000
-40.6%
49,327
-5.2%
0.00%
-100.0%
Q4 2021$475,000
-30.5%
52,038
-18.5%
0.00%0.0%
Q3 2021$683,000
-50.8%
63,860
-28.5%
0.00%
-50.0%
Q2 2021$1,387,000
-1.8%
89,366
+2.6%
0.00%0.0%
Q1 2021$1,412,000
-9.8%
87,125
+17.8%
0.00%
-33.3%
Q4 2020$1,565,000
+32.2%
73,959
-7.4%
0.00%
+50.0%
Q3 2020$1,184,000
+1.3%
79,868
+0.5%
0.00%
-33.3%
Q2 2020$1,169,000
-30.8%
79,461
-45.1%
0.00%
-40.0%
Q1 2020$1,689,000
-44.5%
144,735
+11.3%
0.01%
-16.7%
Q4 2019$3,045,000
+49.4%
129,990
+18.9%
0.01%
+20.0%
Q3 2019$2,038,000
+0.5%
109,320
+0.8%
0.01%0.0%
Q2 2019$2,027,000
+48.0%
108,461
+90.9%
0.01%
+25.0%
Q1 2019$1,370,000
+25.3%
56,803
+101.9%
0.00%
+33.3%
Q2 2018$1,093,00028,1340.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders